Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States

被引：26

作者：

Bini, Edmund J. ^{[2
,3
]}

Kritz, Steven ^{[1
]}

Brown, Lawrence S., Jr. ^{[4
]}

Robinson, Jim ^{[5
]}

Alderson, Don ^{[6
]}

Rotrosen, John ^{[3
,7
]}

机构：

[1] Addict Res & Treatment Corp, Res Div Med Serv Res & Informat Technol, Brooklyn, NY 11201 USA

[2] VA New York Harbor Healthcare Syst, Div Gastroenterol, New York, NY USA

[3] NYU, Sch Med, New York, NY USA

[4] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA

[5] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA

[6] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, New York, NY 10032 USA

[7] VA New York Harbor Healthcare Syst, Dept Psychiat, New York, NY USA

来源：

JOURNAL OF ADDICTIVE DISEASES | 2011年 / 30卷 / 02期

关键词：

HIV; AIDS; hepatitis C virus; sexually transmitted infections; drug abuse; barriers; INJECTION-DRUG USERS; HIV RISK BEHAVIORS; PREVALENCE; PREVENTION; DISEASES;

D O I：

10.1080/10550887.2011.554780

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

We sought to identify barriers to offering services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections in substance abuse treatment programs. We surveyed treatment program administrators and clinicians within the National Drug Abuse Treatment Clinical Trials Network to evaluate the availability of medical and non-medical services for patients with or at risk for acquiring these infections. A substantial proportion of programs do not offer services (particularly medical services) for these infections. The most commonly cited barriers were funding, health insurance benefits, patient acceptance, and staff training. The findings highlight a missed opportunity to positively impact these infectious disease epidemics.

引用

页码：98 / 109

页数：12

共 28 条

[1]

Anderson JE, 1999, J ACQ IMMUN DEF SYND, V21, P148

[2]

[Anonymous], NSDUH SER H

[3]

[Anonymous], 2005, SEX TRANSM DIS SURV

[4] The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 [J].

Armstrong, Gregory L. ;

Wasley, Annemarie ;

Simard, Edgar P. ;

McQuillan, Geraldine M. ;

Kuhnert, Wendi L. ;

Alter, Miriam J. .

ANNALS OF INTERNAL MEDICINE, 2006, 144 (10) :705-714

[5] Risk and prevalence of treatable sexually transmitted diseases at a Birmingham Substance Abuse Treatment Facility [J].

Bachmann, LH ;

Lewis, I ;

Allen, R ;

Schwebke, JR ;

Leviton, LC ;

Siegal, HA ;

Hook, EW .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (10) :1615-1618

[6]

BATTJES RJ, 1995, J ACQ IMMUN DEF SYND, V10, P90

[7] Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network [J].

Brown, Lawrence S., Jr. ;

Kritz, Steven Allan ;

Goldsmith, R. Jeffrey ;

Bini, Edmund J. ;

Rotrosen, John ;

Baker, Sherryl ;

Robinson, Jim ;

McAuliffe, Patrick .

JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2006, 30 (04) :315-321

[8]

Centers for Disease Control and Prevention, 2021, JAMA-HEALTH FORUM, DOI [DOI 10.1001/jamahealthforum.2021.0325, DOI 10.1037/E547602006-001]

[9]

Fenton K. A., 2006, Morbidity and Mortality Weekly Report, V55, P585

[10]

Francis Henry, 2003, Top HIV Med, V11, P20

← 1 2 3 →